Scientists have made a major breakthrough in neuroscience, developing a novel RNA-based nasal spray, COG-201, that has shown remarkable promise in...
Vous n'êtes pas connecté
WA patients have become the first in the world to access a novel nasal spray treatment for erectile dysfunction, developed by Brisbane-based biotech LTR Pharma that is promising results in 10 minutes.
Scientists have made a major breakthrough in neuroscience, developing a novel RNA-based nasal spray, COG-201, that has shown remarkable promise in...
RNA nasal spray: A groundbreaking innovation in treating memory loss and anxiety, offering new hope for more effective and non-invasive therapies.
Using a novel stem cell platform, a team of the Medical University of South Carolina researchers has identified a pathway that could be targeted by...
USD20 - USD25 per hour: MSI Pharma: MSI Pharma are seeking to fill a position for a Top Biotech Organisation based in the USA. The client is looking...
The first two blood cancer patients in a US-based trial, who had suffered relapses despite having treatment, have now been in remission for up to 120...
AMSTERDAM, Sept. 10, 2024 (GLOBE NEWSWIRE) — The latest report from the Access to Medicine Foundation takes a first-ever look at the critical issue...
AMSTERDAM, Sept. 10, 2024 (GLOBE NEWSWIRE) — The latest report from the Access to Medicine Foundation takes a first-ever look at the critical issue...
AMSTERDAM, Sept. 10, 2024 (GLOBE NEWSWIRE) — The latest report from the Access to Medicine Foundation takes a first-ever look at the critical issue...
AMSTERDAM, Sept. 10, 2024 (GLOBE NEWSWIRE) — The latest report from the Access to Medicine Foundation takes a first-ever look at the critical issue...
AMSTERDAM, Sept. 10, 2024 (GLOBE NEWSWIRE) — The latest report from the Access to Medicine Foundation takes a first-ever look at the critical issue...